Nasus Financial Statements From 2010 to 2025

NSRX Stock   7.50  0.11  1.45%   
Nasus Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nasus Pharma's valuation are provided below:
Nasus Pharma does not presently have any fundamental ratios for analysis.
Check Nasus Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nasus Pharma's main balance sheet or income statement drivers, such as Interest Expense of 35.2 K, Selling General Administrative of 599.7 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0. Nasus financial statements analysis is a perfect complement when working with Nasus Pharma Valuation or Volatility modules.
Check out the analysis of Nasus Pharma Correlation against competitors.
For more information on how to buy Nasus Stock please use our How to Invest in Nasus Pharma guide.

Nasus Pharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets578.6 K717 K447.5 K
Slightly volatile
Other Current Liabilities404.3 K489 K505.5 K
Slightly volatile
Total Current Liabilities4.2 M3.9 M3.4 M
Slightly volatile
Net Debt1.9 M1.5 M1.5 M
Slightly volatile
Accounts Payable553.9 K651 K742.7 K
Slightly volatile
Cash231.4 K284 K169.4 K
Slightly volatile
Common Stock Shares Outstanding7.2 M8.2 M8.9 M
Slightly volatile
Other Current Assets166.9 K146 K234.1 K
Slightly volatile
Total Liabilities4.2 M3.9 M3.4 M
Slightly volatile
Short and Long Term Debt2.1 M1.8 M1.7 M
Slightly volatile
Total Current Assets483.3 K457 K425.3 K
Slightly volatile
Capital Stock15.8 K20 K6.7 K
Slightly volatile

Nasus Pharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense35.2 K29 K21.7 K
Slightly volatile
Selling General Administrative599.7 K743 K872.5 K
Slightly volatile
Other Operating Expenses1.1 M1.1 M1.9 M
Slightly volatile
Research Development538.1 K335 K996.8 K
Slightly volatile
Total Operating Expenses1.1 M1.1 M1.9 M
Slightly volatile

Nasus Pharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings938.9 K1000 K1.4 M
Slightly volatile
Stock Based Compensation19.2 K10 K22.9 K
Very volatile
Change In Working Capital279.7 K405 K440.8 K
Slightly volatile
Begin Period Cash Flow185.3 K210 K290.5 K
Slightly volatile
Other Non Cash Items35.2 K29 K21.7 K
Slightly volatile
Total Cash From Financing Activities878.4 K770 K1.4 M
Slightly volatile
End Period Cash Flow253.7 K311 K187.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Ebt Per Ebit0.91.43971.0573
Very volatile
Net Income Per E B T0.750.98710.8199
Slightly volatile

Nasus Pharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap59.8 M67.3 M73.3 M
Slightly volatile

About Nasus Pharma Financial Statements

Nasus Pharma investors use historical fundamental indicators, such as Nasus Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nasus Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nasus Stock Analysis

When running Nasus Pharma's price analysis, check to measure Nasus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasus Pharma is operating at the current time. Most of Nasus Pharma's value examination focuses on studying past and present price action to predict the probability of Nasus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nasus Pharma's price. Additionally, you may evaluate how the addition of Nasus Pharma to your portfolios can decrease your overall portfolio volatility.